Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Protalix BioTherapeutics (AMEX:PLX) through any online brokerage.
Other companies in Protalix BioTherapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Elicio Therapeutics (NASDAQ:ELTX), Sangamo Therapeutics (NASDAQ:SGMO) and Agenus (NASDAQ:AGEN).
Protalix BioTherapeutics has a consensus price target of $15.00.
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.9302 last updated November 13, 2025 at 5:21 PM EST.
There are no upcoming dividends for Protalix BioTherapeutics.
Protalix BioTherapeutics’s Q3 earnings are confirmed for Thursday, November 13, 2025.
There is no upcoming split for Protalix BioTherapeutics.
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.